Found 575 matching trials
Autologous Polyclonal Tregs for Lupus PHASE1 The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Herbert Irving Comprehensive Cancer Center
Learn More & Join Trial
AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis PHASE1 One of the possible options for the treatment of MS at present is a high-do...
Show More Location
First Pavlov State Medical University of St. Petersburg
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
High Dose Chemotherapy and Autologous Transplant for Breast Cancer PHASE2 To determine survival outcomes for patients with chemosensitive brest cance...
Show More Location
Stanford University Cancer Center
Learn More & Join Trial
Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients PHASE3 Multiple myeloma is a malignant incurable hematological disease where survi...
Show More Location
Hæmatologisk afdeling B, Aalborg Sygehus Syd
Learn More & Join Trial
High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML PHASE2 The purpose of this study is to determine the effectiveness of a particular...
Show More Location
The University of Chicago
Learn More & Join Trial
Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases PHASE1 While glucocorticoids and immunosuppressants ameliorate manifestations of a...
Show More Location
Charité Universitätsmedizin Berlin
Learn More & Join Trial
Neoantigen-expanded Autologous Immune Cell Therapy PHASE1 The investigators aim to investigate the patient's tumor neoantigen to gene...
Show More Location
Chang Gung Memorial Hospital, Linkou
Learn More & Join Trial
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma PHASE2 Patients included in the study will receive induction treatment during 6 mo...
Show More Status
Active Not Recruiting
Location
Hospital Clínic de Barcelona
Learn More & Join Trial